ADR News Bulletin 2026 May (Volume 28 Number 1)

Bulletin Highlights:

• Biosimilars: Transforming healthcare through enhanced patient access

• Analysis of adverse event reports for the year 2025

• AE Case in Focus: Test Yourself - What could have caused the sudden and severe recurrence of pruritus and urticaria in this patient?

Click on the link below to download the issue in PDF:

ADR News May 2026 Vol 28 No 1 [PDF,4275KB]

New drugs approved in 2025:

Healthcare professionals are encouraged to report all serious and non-serious suspected adverse drug reactions (ADRs) with the use of new drugs. Your active participation in the ADR monitoring programme will provide valuable support to the post-marketing surveillance on drug safety.

Click on the link below to download the issue in PDF:

New Drugs Approved for 2025 [PDF, 421KB]

Doctors, dentists and pharmacists can claim continuing education points for reading each issue of the HSA ADR News Bulletin. Doctors can apply for one non-core Continuing Medical Education (CME) point under category 3A, dentists can apply for one Continuing Professional Education (CPE) point under category 3A and pharmacists can apply for one patient-care Continuing Professional Education (CPE) point under category 3A per issue of the bulletin. Each issue of the bulletin is valid for two years.